Summary
Zhiqiang Wang is a Senior Scientist with nine years of combined academic and industry experience translating molecular diagnostics and biomarker discovery into regulated IVD and companion diagnostic products. He holds an MD, MS in Clinical Pathology and a PhD in Experimental Medicine, with postdoctoral training in methylation biology and immuno-oncology, and has led assay development from concept through transfer under ISO 13485 and CLIA/CAP frameworks. His technical breadth spans liquid biopsy, cell-free DNA, DNA methylation, multiplex qPCR/RT-qPCR, digital PCR and NGS, complemented by practical skills in DOE and R/JMP-driven statistical design. At companies including Roche and Thermo Fisher he has driven oncology biomarker programs and CDx efforts, and his background in clinical pathology gives him an uncommon end-to-end perspective on specimen handling, assay robustness and clinical trial integration. A detail many miss: he pairs deep wet-lab expertise with regulatory training (Duke regulatory affairs, UCSD IVD product development), making him effective at navigating both scientific and compliance hurdles.
9 years of coding experience
8 years of employment as a software developer
Doctor of Philosophy (Ph.D.), Experimental Medicine, Doctor of Philosophy (Ph.D.), Experimental Medicine at Université Laval
Regulatory Affairs, Regulatory Affairs at Duke University School of Medicine
Doctor of Medicine - MD, Clinical Medicine, Doctor of Medicine - MD, Clinical Medicine at Zhengzhou University
In Vitro Diagnostics Product Development, In Vitro Diagnostics Product Development at UC San Diego Extended Studies
English, Chinese